A Meta-Analysis of Adjuvant Therapy after Potentially Curative Treatment for Hepatocellular Carcinoma

A Meta-Analysis of Adjuvant Therapy after Potentially Curative Treatment for Hepatocellular Carcinoma

BACKGROUND: The high recurrence rate of hepatocellular carcinoma (HCC) after potentially curative treatment determines the long-term prognosis.

Saved in:

Bibliographic Details
Main Authors:	Jun Wang, Xiao Dong He, Nan Yao, Wen Jia Liang, You Cheng Zhang
Format:	Article
Language:	English
Published:	Wiley 2013-01-01
Series:	Canadian Journal of Gastroenterology
Online Access:	http://dx.doi.org/10.1155/2013/417894
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Antibiotic Prophylaxis in Transarterial Therapy of Hepatocellular Carcinoma: A Meta-Analysis
by: Jun Wang, et al.
Published: (2012-01-01)

Response to: Comment on “Evaluation of Antiviral Therapy Performed after Curative Therapy in Patients with HBV-Related Hepatocellular Carcinoma: An Updated Meta-Analysis”
by: Peng Yuan, et al.
Published: (2016-01-01)

Extrapolating Prognostic Factors of Primary Curative Resection to Postresection Recurrences Hepatocellular Carcinoma Treatable by Radiofrequency Ablation
by: Hui Ma, et al.
Published: (2021-01-01)

Use of Adjuvant Sorafenib in Liver Transplant Recipients with High-Risk Hepatocellular Carcinoma
by: Kirti Shetty, et al.
Published: (2014-01-01)

Targeted Therapy in Hepatocellular Carcinoma
by: Clarinda W. L. Chua, et al.
Published: (2011-01-01)

Emerging nanomedicine strategies for hepatocellular carcinoma therapy
by: Chen Guo, et al.
Published: (2024-09-01)

The Clinical Characteristics, Patterns of Recurrence, and Long-Term Survival Outcomes of Dual-Phenotype Hepatocellular Carcinoma After Curative Liver Resection
by: Yu ZC, et al.
Published: (2025-01-01)

The Role of Bridging Therapy in Hepatocellular Carcinoma
by: Roberto Galuppo, et al.
Published: (2013-01-01)

Diagnosis, Therapy, and Prognosis for Hepatocellular Carcinoma
by: Zhigang Ren, et al.
Published: (2020-01-01)

A Meta-Analysis of Statin Use and Risk of Hepatocellular Carcinoma
by: Yikai Wang, et al.
Published: (2022-01-01)

The prognostic value of systemic immune-inflammation index in patients with unresectable hepatocellular carcinoma treated with immune-based therapy
by: Tian He, et al.
Published: (2025-01-01)

Exploring Glypican-3 targeted CAR-NK treatment and potential therapy resistance in hepatocellular carcinoma.
by: Lei Yang, et al.
Published: (2025-01-01)

Probing the Hepatic Progenitor Cell in Human Hepatocellular Carcinoma
by: Shu-Qin Jia, et al.
Published: (2013-01-01)

Diagnostic Performance of Des-γ-carboxy Prothrombin for Hepatocellular Carcinoma: A Meta-Analysis
by: Rong Zhu, et al.
Published: (2014-01-01)

Gut Microbiome in Obsessive Compulsive Disorder: Potential of Probiotics as an Adjuvant Therapy
by: Grace Yong-En Kong, et al.
Published: (2022-11-01)

Functionalized Selenium Nanoparticles Enhance Anticancer Efficacy of Doxorubicin for Hepatocellular Carcinoma Therapy
by: Min Guo, et al.
Published: (2022-01-01)

High Expression of Ten Eleven Translocation 1 Is Associated with Poor Prognosis in Hepatocellular Carcinoma
by: Haopeng Wen, et al.
Published: (2023-01-01)

Identification of Hepatocellular Carcinoma Subtypes Based on Global Gene Expression Profiling to Predict the Prognosis and Potential Therapeutic Drugs
by: Cunzhen Zhang, et al.
Published: (2025-01-01)

Comprehensive Landscape of ARID Family Members and Their Association with Prognosis and Tumor Microenvironment in Hepatocellular Carcinoma
by: Ji Sun, et al.
Published: (2022-01-01)

Study of RNA Interference Targeting NET-1 Combination with Sorafenib for Hepatocellular Carcinoma Therapy In Vitro and In Vivo
by: Song He, et al.
Published: (2013-01-01)

Risk factors for hepatocellular carcinoma: an umbrella review of systematic review and meta-analysis
by: Jie Wang, et al.
Published: (2025-12-01)

Real world study on combining local interventions with systemic therapy in unresectable hepatocellular carcinoma
by: Zhaosong Xue, et al.
Published: (2025-02-01)

Lenvatinib Therapy in Patients with Unresectable Hepatocellular Carcinoma in Real Clinical Practice
by: V. V. Petkau, et al.
Published: (2022-12-01)

Dramatic Reduction in Tumour Size in Hepatocellular Carcinoma Patients on Thalidomide Therapy
by: Denny Demeria, et al.
Published: (2007-01-01)

Epidemiology of Hepatocellular Carcinoma
by: Mimi C Yu, et al.
Published: (2000-01-01)

Biomarkers for Hepatocellular Carcinoma
by: Tara Behne, et al.
Published: (2012-01-01)

Identification and Validation of a Potential Stemness-Associated Biomarker in Hepatocellular Carcinoma
by: Yangyang Zhang, et al.
Published: (2022-01-01)

Hepatic arterial infusion chemotherapy combined with systemic therapy sequentially or simultaneously for advanced hepatocellular carcinoma
by: Yu-zhe Cao, et al.
Published: (2024-11-01)

Efficacy and safety of Saccharomyces boulardii as an adjuvant therapy for the eradication of Helicobacter pylori: a meta-analysis
by: Manning Li, et al.
Published: (2025-02-01)

The Efficacy of Flupentixol-Melitracen in the Adjuvant Therapy of Ulcerative Colitis in the Chinese Population: A Meta-Analysis
by: Xiaoqian Zhou, et al.
Published: (2019-01-01)

Elevated Preoperative Neutrophil-Lymphocyte Ratio Is Associated with Poor Prognosis in Hepatocellular Carcinoma Patients Treated with Liver Transplantation: A Meta-Analysis
by: Xiao-Dong Sun, et al.
Published: (2016-01-01)

Prognostic Role of Platelet-to-Lymphocyte Ratio in Hepatocellular Carcinoma with Different BCLC Stages: A Systematic Review and Meta-Analysis
by: Wan-fu Lin, et al.
Published: (2018-01-01)

Metabolic Alteration in Hepatocellular Carcinoma: Mechanism of Lipid Accumulation in Well-Differentiated Hepatocellular Carcinoma
by: Hideo Suzuki, et al.
Published: (2021-01-01)

TMEM147 Correlates with Immune Infiltration and Serve as a Potential Prognostic Biomarker in Hepatocellular Carcinoma
by: Sheng Cheng, et al.
Published: (2023-01-01)

Immune infiltration landscape and potential drug-targeted implications for hepatocellular carcinoma with ‘progression/hyper-progression’ recurrence
by: Jing-Xuan Xu, et al.
Published: (2025-12-01)

Acupuncture as an independent or adjuvant therapy to standard management for menopausal insomnia: A systematic review and meta-analysis.
by: Xiaoni Zhang, et al.
Published: (2025-01-01)

Acupuncture as an independent or adjuvant therapy to standard management for menopausal insomnia: A systematic review and meta-analysis
by: Xiaoni Zhang, et al.
Published: (2025-01-01)

NOL-7 serves as a potential prognostic-related biomarker for hepatocellular carcinoma
by: Qiucheng Lei, et al.
Published: (2025-01-01)

Hepatocellular Carcinoma to the Right Ventricle
by: George R. Marzouka, et al.
Published: (2014-01-01)

RECIST 1.1 versus mRECIST for assessment of tumour response to molecular targeted therapies and disease outcomes in patients with hepatocellular carcinoma: a systematic review and meta-analysis
by: Yao Yang, et al.
Published: (2022-06-01)